parapneumonic syndrome.ppt

28
PARAPNEUMONIC SYNDROME (Laporan Kasus) Arismunandar H.P.U 0818011008 1

Upload: saga-sabara

Post on 13-Apr-2015

56 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: PARAPNEUMONIC SYNDROME.ppt

PARAPNEUMONIC SYNDROME(Laporan Kasus)

  Arismunandar H.P.U

0818011008

1

Page 2: PARAPNEUMONIC SYNDROME.ppt

Identitas PasienNama : Tn. S

Umur : 60 tahun Jenis Kelamin : Laki-laki Pekerjaan : Petani Agama : Islam Alamat : Punggur Tanggal Masuk : 19 Januari 2013,

pukul 18.00 WIB

2

1. ANAMNESIS

Page 3: PARAPNEUMONIC SYNDROME.ppt

Keluhan UtamaBuang air besar cair sejak 1 hari SMRS Keluhan TambahanDemam,batuk berdahak, pilek, sesak

3

Page 4: PARAPNEUMONIC SYNDROME.ppt

Riwayat Penyakit Sekarang Pasien datang ke IGD RSAY Metro dengan keluhan

buang air besar cair sejak 1 hari SMRS. Buang air besar sebanyak 5 kali dengan konsistensi cair, ampas yang sedikit dan berlendir tanpa disertai darah. Pasien juga mengeluh demam yang naik turun sejak 2 hari SMRS dan disertai dengan pilek dan batuk berdahak, dahak berwarna hijau tanpa disertai darah. Pasien juga mengeluh sesak nafas dan dada terasa berat sejak 2 hari SMRS. Sesak nafas timbul saat istirahat dan tidak diperberat oleh aktivitas. Pasien juga mengaku tidak nafsu makan dan badan terasa lemas. Karena khawatir akan kondisi dirinya, maka pasien datang ke IGD RSAY Metro untuk berobat.

4

Page 5: PARAPNEUMONIC SYNDROME.ppt

Riwayat Penyakit Dahulu

Riwayat kencing manis : disangkal Riwayat darah tinggi : disangkal Riwayat sakit jantung : disangkal Riwayat minum OAT :

disangkal Pasien belum pernah

mengalami sakit seperti ini sebelumnya

5

RiwayatPenyakit Keluarga

Riwayat penyakit serupa : disangkal

Riwayat darah tinggi : disangkal

Riwayat kencing manis : disangkal

Page 6: PARAPNEUMONIC SYNDROME.ppt

PEMERIKSAAN FISIKKeadaan Umum : sakit berat, compos

mentis, gizi kurang (berat badan 45 kg,

tinggi badan 1,67 m, BMI = 16,1)

Tanda Vital Tekanan darah : 60/40 mmHg Nadi : 124 x/menit , cepat dan lemah

Pernapasan : 40 x/menit Suhu : 38,7 °C Saturasi O2 : 90 %

6

Page 7: PARAPNEUMONIC SYNDROME.ppt

Kepala : normochepal, simetris. Mata : Conjungtiva anemis (-/-), sclera ikterik (-/-) Pupil isokor (3 mm/3mm), Reflek

cahaya (+/+). Hidung: Nafas cuping hidung (+), darah (-), secret (-). Telinga : darah (-), secret (-). Mulut : mukosa basah (+), sianosis (-), lidah kotor (-). Leher : Simetris, limfonodi coli tidak membesar. Thorax: retraksi intercostal (+)

7

Page 8: PARAPNEUMONIC SYNDROME.ppt

Jantung Inspeksi : ictus cordis tidak tampak Palpasi : ictus cordis tidak

teraba Perkusi : batas jantung

dalam batas normal Auskultasi : BJ I-II intensitas normal,

reguler, murmur (-), gallop (-) Paru Inspeksi : Saat statis bagian dada kanan sama

dengan bagian kiri, saat dinamis, gerakan dada kanan tertinggal dari kiri. Retraksi intercostal, dan subcostal ditemukan

Palpasi : Fremitus taktil kanan lebih lemah dari kiri

Perkusi : pekak/sonor Auskultasi : ronki +/-, wheezing -/-

8

Page 9: PARAPNEUMONIC SYNDROME.ppt

Abdomen Inspeksi : tampak datar, dinding

perut sejajar dengan dinding dada

Auskultasi : bising usus (+) Perkusi : Tympani Palpasi : Supel, nyeri tekan

(-), hepar/lien tidak teraba Trunk Inspeksi : Skoliosis (-), kifosis (-), lordosis

(-) Palpasi : Nyeri tekan (-), massa (-) Perkusi : Nyeri ketok (-) Ekstremitas: Oedem -/- Akral dingin -/-

9

Page 10: PARAPNEUMONIC SYNDROME.ppt

PEMERIKSAAN PENUNJANG Laboratorium (19 Januari 2013) : DL :

Hb : 9,5 g/dL WBC : 34.600 /ul RBC : 4,46 juta /ul

PLT : 437.000 /ul GDS : 94 mg/dL Ureum : 66,2 mg/dL Kreatinin : 2,02 mg/dL SGOT : 69,8 U/L SGPT : 33,4 U/L Albumin : 2,7 g/dL Globulin : 1,74 g/dL

10

Page 11: PARAPNEUMONIC SYNDROME.ppt

UL : leukosit 10/ul, eritrosit 30/uL, epitel ++ Feses lengkap : macros : konsistensi lembek,

lendir, darah negatif micros : leukosit, eritrosit

negatif BTA sputum S-P-S : negatif-negatif-

negatif Kultur darah (22-1-2013) : hasil steril

11

Page 12: PARAPNEUMONIC SYNDROME.ppt

Foto Rontgen Thorax PA (23 Januari 2013) :

12

• Kesan:• Efusi pleura

dextra• bronkopneumon

ia• kardiomegali

dengan elongatio aorta

Page 13: PARAPNEUMONIC SYNDROME.ppt

USG Abdomen (21 Januari 2013) : Complex pleural effusion supradiafragma dextra Pielonefritis sinistra Hepar,, lien, pancreas, vesica urinaria dalam batas normal

Dilakukan pungsi pleura pada tanggal 19 januari 2013, kemudian dilakukan analisa dan sitologi cairan pleura, hasil :

Analisa cairan pleura (21-1-2013) : Protein total serum : 5,76 g/dL, ratio 0,8 LDH serum : 291 U/L, ratio 3,2 Glukosa : 72 mg/dL Pewarnaan BTA : negatif, pewarnaan gram : kokus gram positif Sifat cairan pleura adalah eksudat dengan infeksi sekunder oleh kuman kokus gram

positif.

Patologi anatomi cairan pleura (24-1-2013) : Sel malignancy negative Peradangan kronis supuratif (abses)

13

Page 14: PARAPNEUMONIC SYNDROME.ppt

Diagnosa kerja: 1.Pneumonia dengan efusi pleura dextra

(parapneumonic syndrome) 2. Syok sepsis

2.Diarrhea3. Malnutrisi underweight

5. PENATALAKSANAAN O2 2L/mnt IVFD RL guyur 1 liter – maintenance 40 tetes/menit Levofloxacin 1 x 750 mg i.v Ceftriaxone 2 x gr i.v Metronidazol 3 x 500 mg i.v Ranitidine 2 x 1 amp i.v Metoclopramid 2 x 1 amp i.v Diet : TKTP Nasi + ekstra telur   6. PROGNOSIS Ad vitam : dubia Ad sanam : dubia Ad fungsionam : dubia

14

Page 15: PARAPNEUMONIC SYNDROME.ppt

15

PARAPNEUMONIC SYNDROME

Page 16: PARAPNEUMONIC SYNDROME.ppt

Parapneumonic syndrome : Pneumonia symptoms with parapneumonic

effusion (exudative pleural effusion) that results from pneumonia (CAP/NP) or lung abses

Between 20% and 57% of the 1 million patients hospitalized yearly in the U.S with pneumonia, develop a PPE.

Empyema is less common, occurring in 5%–10% of patients who experience PPE

16

INTRODUCTION

Page 17: PARAPNEUMONIC SYNDROME.ppt

Figure 1. Causes of empyema in 14 prior studies. Of the 1383 patients in the studies, 70% were parapneumonic. For the other 30% of patients, trauma was the cause of empyema in 7%, empyema was postoperative in 6%, and prior tuberculosis was the cause in 4%; 12% of cases were due to other causes.

17

Page 18: PARAPNEUMONIC SYNDROME.ppt

Clinical classificationof PPE : 1. uncomplicated parapneumonic effusion (UPPE) 2. complicated parapneumonic effusion (CPPE) 3. Empyema

Stages : 1. exudative 2. fibrinopurulent 3. final organizational

18

CLASSIFICATION

Page 19: PARAPNEUMONIC SYNDROME.ppt

Symptoms of pneumonia : Fever, malaise, cough, dyspnea, pleuritic

chest pain Eldery patients >> asymptomatic

19

CLINICAL PRESENTATION

Page 20: PARAPNEUMONIC SYNDROME.ppt

Pleural fluid analysis >>> to stage the PPE and guides initial management.

UPPEs : have a turbid appearance, with a pH >7.30, a glucose level >60 mg/dL, an LDH level <700 IU/L, and negative microbiologic test results.

CPPEs : pleural fluid pH <7.20, a glucose level <40 mg/dL, and an LDH level >1000 IU/L; Gram stain and culture results may be positive.

Pus aspirated from the pleural space is diagnostic of empyema,20

Page 21: PARAPNEUMONIC SYNDROME.ppt

21

Page 22: PARAPNEUMONIC SYNDROME.ppt

recommended that all patients with pneumonia be evaluated for the presence of pleural fluid.

With the possible or definite presence of pleural fluid noted on a chest radiograph, an ultrasound-guided thoracentesis should be performed.

Ultrasonography can detect stranding or septation in the fluid suggestive of a CPPE and can facilitate its drainage.

22

Page 23: PARAPNEUMONIC SYNDROME.ppt

Figure 3. A complex, septate pleural effusion demonstrated by ultrasonography in a patient with spontaneous hemorrhage into a pre-existing pleural effusion. This precise pattern is typical of a complicated parapneumoniceffusion as well.

  23

Page 24: PARAPNEUMONIC SYNDROME.ppt

Figure 2. The estimated time course of untreated or inappropriately treated parapneumonic effusions. In general, an empyema will develop 4–6 weeks after the onset of aspiration of bacteria into the lung.

24

PATHOPHYSIOLOGY

Page 25: PARAPNEUMONIC SYNDROME.ppt

In general, early and appropriate antibiotic treatment will prevent the development of a PPE and its progression.

25

MANAGEMENT

Page 26: PARAPNEUMONIC SYNDROME.ppt

Antibiotic therapy : Early antibiotic therapy will prevent the development of a PPE and its progression to a CPPE and empyema.

Pleural space drainage : Clinical factors that suggest pleural space drainage include :

prolonged pneumonia symptoms, Comorbid disease, failure to respond to antibiotic therapy, and presence of anaerobic organisms .

Chest radiograph findings that suggest the need for pleural space drainage include an effusion involving >50% of the hemothorax

Stranding or septation noted on an ultrasound suggests the need for pleural space drainage.

Intrapleural fibrinolytics : fibrinolytic agents (urokinase and tissue plasminogen activator) most effective in the early fibrinolytic stage in avoiding the need for surgical drainage.

Surgery : pleural space drainage by tube thoracostomy has been ineffective in controlling the pleural infection. (VATS).26

MANAGEMENT

Page 27: PARAPNEUMONIC SYNDROME.ppt

1. Early antibiotic treatment usually prevents the development of a PPE and its progression to a complicated PPE and empyema.

2. Pleural fluid analysis provides diagnostic information and guides therapy.

3. If the PPE is small to moderate in size, free-flowing, and nonpurulent (pH, >7.30), it is highly likely that antibiotic treatment alone will be effective.

4. Prolonged pneumonia symptoms before evaluation, pleural fluid with a pH <7.20, and loculated pleural fluid suggest the need for pleural space drainage.

5. The presence of pus (empyema) aspirated from the pleural space always requires drainage.

6. Fibrinolytics are most likely to be effective during the early fibrinolytic stage and may make surgical

drainage unnecessary.

7. If pleural space drainage is ineffective, video-assisted thoracic surgery should be performed without delay.

27

CONCLUSIONS

Page 28: PARAPNEUMONIC SYNDROME.ppt

28

TERIMA KASIH